IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Consonance Capital Management LP

Q3 2014 Holdings

Filed 2014-11-14 | 26 holdings | $57.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$33.4M579,10058.0%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$15.5M549,82727.0%
Adma Biologics Inc(ADMA)COM000899104$8.0M776,86313.9%
United Therapeutics Corp del(UTHR)COM91307C102$98.0K761,7620.2%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$63.3K1,599,1090.1%
Taro Pharmaceutical Inds LTDSHSM8737E108$47.9K311,2340.1%
Cardiovascular SYS Inc del(CSIIEUR)COM141619106$45.9K1,943,0540.1%
Auxilium Pharmaceuticals IncCOM05334D107$44.6K1,493,5600.1%
Orthofix Intl N VCOMN6748L102$44.5K1,436,4950.1%
Insys Therapeutics Inc NewCOM NEW45824V209$43.4K1,119,9170.1%
Akorn Inc(AKRXEUR)COM009728106$42.6K1,173,4850.1%
Hyperion Therapeutics IncCOM44915N101$31.9K1,263,0340.1%
Pernix Therapeutics Hldgs inCOM71426V108$26.4K3,443,1370.0%
Anacor Pharmaceuticals IncCOM032420101$25.4K1,038,5530.0%
Bioscrip Inc(BIOSEUR)COM09069N108$21.8K3,153,9520.0%
HMS Hldgs Corp(HMSY)COM40425J101$21.2K1,123,1260.0%
Osiris Therapeutics Inc NewCOM68827R108$19.9K1,579,5610.0%
Relypsa IncCOM759531106$13.9K660,4620.0%
Retrophin IncCOM761299106$13.9K1,539,4590.0%
Merrimack Pharmaceuticals inCOM590328100$13.5K1,536,9020.0%
Derma Sciences IncCOM PAR $.01249827502$12.7K1,520,4040.0%
Protalix Biotherapeutics IncCOM74365A101$12.2K5,027,3380.0%
Healthways IncCOM422245100$11.2K698,1900.0%
Aastrom Biosciences IncCOM PAR$00253U404$6.7K2,352,9400.0%
IGI Labs IncCOM449575109$6.7K719,2780.0%
Healthstream Inc(HSTM)COM42222N103$4.2K173,8330.0%